Montanova Capital, LLC's Form 4 filing
Benitec Biopharma Inc. (BNTC) · filed Dec 5, 2024
- Accession no.
- 0000899140-24-001318
- Filed
- Dec 5, 2024, 4:36 PM ET
- Trade date
- Dec 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $403.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Montanova Capital, LLCCIK 0001569064 | Director, 10% Owner |
| Averill Master Fund, Ltd.CIK 0001939329 | Director, 10% Owner |
| Averill Madison Master Fund, Ltd.CIK 0002021243 | Director, 10% Owner |
| Cowen AaronCIK 0001869640 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2024 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +37,190 | $9.60 | +$357,024 | 7,957,365 | Indirect | |
| Dec 3, 2024 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +4,810 | $9.60 | +$46,176 | 955,124 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.